Definitive Contract 75N93025C00023
Award Date
8/1/25
Potential Completion Date
7/31/30
Potential Value
$2.7M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Hbvtech, L.l.c
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.55 million definitive cost plus fixed fee contract to Hbvtech of Germantown, Maryland to perform work under Small Business Innovation Research Phase II Topic 84, entitled "Antiviral Drugs to Cure Chronic Hepatitis B Virus Infection." The contract period of performance spans from September 1, 2022 through August 25, 2025. Under this award,...
This SBIR Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases, valued at $299,868, was awarded to Hbvtech of Germantown, Maryland. The contract supports research outlined in Topic 084 of the solicitation, which sought proposals for antiviral drugs to cure chronic hepatitis B virus infection. The firm-fixed price contract is a total small business set-aside running from August 2020 through October 2021. The award advances the NIH/NIAID's...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 firm fixed price definitive contract to Zymeron Corporation under SBIR PHS 2020-1 Topic 084. This Small Business Innovation Research Phase I contract supports research and development of antiviral drugs to cure chronic hepatitis B virus infection. The solicitation sought proposals for Phase I and Phase II SBIR contracts to advance the missions of...
This definitive contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Casterbridge Pharmaceuticals, Inc. of Woburn, Massachusetts. The $297,245 firm fixed price contract is for research under Phase I of the Small Business Innovation Research program's Topic 084 entitled "Antiviral Drugs to Cure Chronic Hepatitis B Virus Infection." The place of performance is the prime contractor's facility in Woburn. The period of...
<p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
This is a $1,500,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Cure Systems LLC, a self-certified small disadvantaged business located in Newton, Massachusetts. The contract is for the research and development of "Vector-Based Delivery of HIV Broadly Neutralizing Antibodies," a specialized approach to developing advanced...
This definitive contract from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awards Regulus Therapeutics Inc. $300,000 under the SBIR PHS 2020-1 Topic 084 solicitation. The solicitation sought proposals to conduct research and development in support of developing antiviral drugs to cure chronic hepatitis B virus infection. This is a firm fixed price, total small business set-aside contract to be...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Institute of Liver and Billiary Sciences, a for-profit foreign-owned organization. The contract, valued at $25,000.00, is to develop an integrative, novel collaborative research program in the area of HIV, hepatitis, and hepatocellular carcinoma. The contract was awarded on September 19, 2012, with an...
This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...